Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies (2022)

First Author: Beesley R
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.msard.2022.104121

Publication URI: http://dx.doi.org/10.1016/j.msard.2022.104121

Type: Journal Article/Review

Parent Publication: Multiple Sclerosis and Related Disorders